BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Press Releases

  Terumo Neuro Signs Agreement to Acquire Arsenal Medical – Advancing Next-Generation Liquid Embolic Innovation for Treating Chronic Subdural Hematoma (cSDH)

  September 30, 2026

   · 

  6 min read
• Press Releases

  Increase in Number of Shares and Votes in Vicore Pharma - September 30, 2026

  September 30, 2026

   · 

  1 min read
• Press Releases

  Italfarmaco Presents New Givinostat (Duvyzat®) Clinical Data Supporting Preservation of Upper Limb Function in Duchenne Muscular Dystrophy Patients at the 2026 World Muscle Society Congress

  September 30, 2026

   · 

  5 min read
• Press Releases

  Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in Advanced Squamous Cell Cancers

  September 30, 2026

   · 

  6 min read
• Press Releases

  Newronika Announces First Participant Implanted in ADVENT Pivotal Study

  September 30, 2026

   · 

  4 min read
• Press Releases

  Rznomics Receives Positive Opinion for Orphan Medicinal Product Designation of RZ-001 for Glioma

  September 30, 2026

   · 

  3 min read
• Press Releases

  Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis’ Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026

  September 30, 2026

   · 

  11 min read
• Press Releases

  Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

  September 30, 2026

   · 

  4 min read
• Press Releases

  People switching from weight-loss injections to Novo’s Wegovy® pill lost 4.1% body weight on average after three months, according to real-world data presented at EASD2026

  September 30, 2026

   · 

  8 min read
• Press Releases

  Astrocyte Pharmaceuticals Secures $9.5 Million Series B to Advance Phase 2 Clinical Development of Breakthrough TBI and Concussion Therapy AST-004

  September 30, 2026

   · 

  4 min read